BR9713916A - Compostos, processo para a preparação dos mesmos, e, composição farmacêutica. - Google Patents

Compostos, processo para a preparação dos mesmos, e, composição farmacêutica.

Info

Publication number
BR9713916A
BR9713916A BR9713916-5A BR9713916A BR9713916A BR 9713916 A BR9713916 A BR 9713916A BR 9713916 A BR9713916 A BR 9713916A BR 9713916 A BR9713916 A BR 9713916A
Authority
BR
Brazil
Prior art keywords
alkyl
alkoxy
alkoxycarbonyl
mono
group
Prior art date
Application number
BR9713916-5A
Other languages
English (en)
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BR9713916A publication Critical patent/BR9713916A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

"COMPOSTOS, PROCESSO PARA A PREPARAçãO DOS MESMOS, E, COMPOSIçãO FARMACêUTICA" A invenção refere-se aos compostos de fórmula (I): na qual Y representa -CH- ou -N-; R~ 1~ representa hidrogênio, um halogênio, um grupo CF~ 3~, alquila (C~ 1~-C~ 4~); ou alcoxila (C~ 1~-C~ 4~) R~ 2~ representa um grupo metila ou etila; R~ 3~ e R~ 4~ representam cada um hidrogênio ou uma alquila (C~ 1~-C~ 3~); X representa (a) uma alquila (C~ 1~-C~ 6~), uma alcoxila (C~ 1~-C~ 6~); carboxialquila (C~ 3~-C~ 7~); alcoxicarbonil (C~ 1~-C~ 4~)alquila (C~ 1~-C~ 6~), carboxialcoxila (C~ 3~-C~ 7~); ou alcoxicarbonil(C~ 1~-C~ 4~) alcoxila (C~ 1~-C~ 6~); (b) um radical selecionado dentre cicloalquila(C~ 3~-C~ 7~), cicloalquiloxi(C~ 3~-C~ 7~), cicloalquilmetila(C~ 3~-C~ 7~), cicloalquilamino (C~ 3~-C~ 7~) e ciclo-hexenila, o referido radical podendo ser substituído por um halogênio, hidróxi, alcoxi (C~ 1~-C~ 4~), carbóxi, alcoxicarbonila (C~ 1~-C~ 4~), amino, mono- ou di-alquilamino (C~ 1~-C~ 4~); ou (c) um grupo selecionado dentre um fenila, fenóxi, fenilamino, N-(C~ 1~-C~ 3~)alquilfenilamino, fenilmetila, feniletila, fenilcarbonila, feniltio, fenilsufonila, fenilsulfinila ou estirila, o referido grupo podendo ser mono- ou poli-substituído sobre o grupo fenila por um halogênio, CF~ 3~, alquila (C~ 1~-C~ 4~), alcoxi (C~ 1~-C~ 4~), ciano, amino, mono- ou di-alquilamino (C~ 1~-C~ 4~), acilamino (C~ 1~-C~ 4~), carbóxi, alcoxicarbonila (C~ 1~-C~ 4~), aminocarbonila, mono- ou di- alquilaminocarbonila (C~ 1~-C~ 4~), amino alquila (C~ 1~-C~ 4~), hidróxi alquila (C~ 1~-C~ 4~)
BR9713916-5A 1996-12-13 1997-12-12 Compostos, processo para a preparação dos mesmos, e, composição farmacêutica. BR9713916A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615335A FR2757160B1 (fr) 1996-12-13 1996-12-13 1-phenylalkyl-1,2,3,6-tetrahydropyridines
PCT/FR1997/002286 WO1998025903A1 (fr) 1996-12-13 1997-12-12 1-phenylalkyl-1,2,3,6-tetrahydropyridines pour le traitement de la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
BR9713916A true BR9713916A (pt) 2000-02-29

Family

ID=9498641

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713916-5A BR9713916A (pt) 1996-12-13 1997-12-12 Compostos, processo para a preparação dos mesmos, e, composição farmacêutica.

Country Status (32)

Country Link
US (1) US6034090A (pt)
EP (1) EP0950048B1 (pt)
JP (1) JP3881384B2 (pt)
KR (1) KR100560358B1 (pt)
CN (1) CN1129579C (pt)
AT (1) ATE202561T1 (pt)
AU (1) AU730143B2 (pt)
BR (1) BR9713916A (pt)
CA (1) CA2275353C (pt)
CY (1) CY2274B1 (pt)
CZ (1) CZ289789B6 (pt)
DE (1) DE69705429T2 (pt)
DK (1) DK0950048T3 (pt)
EE (1) EE03763B1 (pt)
ES (1) ES2160977T3 (pt)
FR (1) FR2757160B1 (pt)
GR (1) GR3036643T3 (pt)
HK (1) HK1023997A1 (pt)
HU (1) HU224347B1 (pt)
IL (1) IL130003A (pt)
IS (1) IS1969B (pt)
NO (1) NO312720B1 (pt)
NZ (1) NZ336033A (pt)
PL (1) PL190789B1 (pt)
PT (1) PT950048E (pt)
RS (1) RS49807B (pt)
RU (1) RU2189975C2 (pt)
SI (1) SI0950048T1 (pt)
SK (1) SK283331B6 (pt)
TR (1) TR199901291T2 (pt)
UA (1) UA52707C2 (pt)
WO (1) WO1998025903A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
FR2832405B1 (fr) * 2001-11-19 2004-12-10 Sanofi Synthelabo Tetrahydropyridyl-alkyl-heterocycles azotes, procede pour leur preparation et compositions pharmaceutiques les contenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds

Also Published As

Publication number Publication date
JP3881384B2 (ja) 2007-02-14
DE69705429D1 (de) 2001-08-02
PT950048E (pt) 2001-12-28
NO992869L (no) 1999-06-11
AU730143B2 (en) 2001-03-01
DK0950048T3 (da) 2001-09-24
NO992869D0 (no) 1999-06-11
HU224347B1 (hu) 2005-08-29
TR199901291T2 (xx) 1999-10-21
IL130003A (en) 2004-09-27
HUP0001185A3 (en) 2002-10-28
CZ211399A3 (cs) 2000-09-13
KR100560358B1 (ko) 2006-03-14
IL130003A0 (en) 2000-02-29
SK283331B6 (sk) 2003-06-03
CA2275353C (en) 2007-05-22
CY2274B1 (en) 2003-07-04
CN1129579C (zh) 2003-12-03
EE9900237A (et) 1999-12-15
HUP0001185A2 (hu) 2000-10-28
CZ289789B6 (cs) 2002-04-17
ES2160977T3 (es) 2001-11-16
WO1998025903A1 (fr) 1998-06-18
RU2189975C2 (ru) 2002-09-27
JP2001505902A (ja) 2001-05-08
US6034090A (en) 2000-03-07
YU24399A (sh) 2001-07-10
FR2757160A1 (fr) 1998-06-19
CA2275353A1 (en) 1998-06-18
IS1969B (is) 2004-12-15
NZ336033A (en) 2000-12-22
EP0950048A1 (fr) 1999-10-20
CN1240427A (zh) 2000-01-05
KR20000069422A (ko) 2000-11-25
EE03763B1 (et) 2002-06-17
UA52707C2 (uk) 2003-01-15
RS49807B (sr) 2008-08-07
GR3036643T3 (en) 2001-12-31
NO312720B1 (no) 2002-06-24
PL190789B1 (pl) 2006-01-31
AU5489398A (en) 1998-07-03
SK78699A3 (en) 2000-01-18
IS5075A (is) 1999-06-10
FR2757160B1 (fr) 1999-03-12
DE69705429T2 (de) 2002-05-16
PL334071A1 (en) 2000-01-31
ATE202561T1 (de) 2001-07-15
SI0950048T1 (en) 2001-10-31
EP0950048B1 (fr) 2001-06-27
HK1023997A1 (en) 2000-09-29

Similar Documents

Publication Publication Date Title
BR9714787A (pt) Compostos de 4- fenilpiperidina e processo para sua preparação
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
BR0111596A (pt) Composto e seu uso, processo para sua produção, composição farmacêutica e processo e método para prevenir ou tratar doenças
DE3667378D1 (de) Verwendung von n-(4-phenoxy-2,6-diisopropylphenyl)-n'-tert.butylthioharnstoff zur bekaempfung von weissen fliegen.
BR9607965A (pt) Composto composição farmacêutica e processo para tratar uma doença parasítica em um mamífero
PT1149910E (pt) Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus
BR9814134A (pt) Derivados de ácido isotiazolcarboxìlico
BR9713916A (pt) Compostos, processo para a preparação dos mesmos, e, composição farmacêutica.
ATE300526T1 (de) Verfahren zur herstellung von 2-(2,4- dihydroxyphenyl) or 2-(2,4-dialkoxyphenyl) -4,6- bisaryl-1,3,5-triazine
DK0748795T3 (da) Substituerede benzyloxycarbonylguanidiner som inhibitorer af Na+/H+-ombytningen, fremgangsmåde til deres fremstilling, dere
ES2173513T3 (es) Composiciones fungicidas.
PT98957A (pt) Processo para a preparacao de composicoes herbicidas contendo derivados de ureia, glicina, piridilio e piridinio
DE59608718D1 (de) Verfahren zur herstellung von substituierten 4,4'-diaminostilben-2,2'-disulfonsäuresalzen
DE69734764D1 (de) Eine amidgruppe tragende schwefelhaltige verbindungen, verfahren zu ihrer herstellung, deren verwendung in medikamenten und sie enthaltende pharmazeutische zubereitungen
BR9803351A (pt) Matriz pesticida revestida, processos para a preparação da mesma e para aperfeiçoar o controle residual de uma praga, e, composição pesticida em pó umectável.
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
SE9602822D0 (sv) New receptor
BR9605374A (pt) Processo para estabilizar 2-metil-4-isotiazolin-3-ona 2-n-octil-4-isotiazolin-3-ona ou uma mistura das mesmas em uma composição e composição
BR9808729A (pt) Processo para a preparação de um anti-oxidante
BR9911679A (pt) Sais de paroxetina
BR9909260A (pt) Processo para o preparo de (r)-alfa-(2,3-dimetóxifenil)-1-[2-(4-fluoro-fenil)etil]-4-pi peridinametanol
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
NO981340L (no) Stabiliserte fosfolipidsammensetninger
DK0679646T3 (da) Sulfonylurinstoffer som herbicider
NO973230L (no) Nye peptider, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
PC Transfer

Free format text: SANOFI-SYNTHELABO (FR)

B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE INCIDE NO ART. 8O, 13 E 24 DA LPI